Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Optinose Inc
(NQ:
OPTN
)
4.190
USD
-0.050 (-1.18%)
Official Closing Price
Updated: 4:23 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Optinose Inc
< Previous
1
2
3
4
5
6
7
8
Next >
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
May 07, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ...
Tags
XERS
ELAN
GNMK
From
Benzinga
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
May 03, 2020
Biotech stocks started last weekon a strong note but the upward momentum slowed through the week. The week saw a slew of earnings ...
Tags
BMY
MRSN
AKBA
From
Benzinga
Optinose to Report First Quarter 2020 Financial Results and Corporate Updates on May 7, 2020
April 30, 2020
From
GlobeNewswire News Releases
Analysts Predict 51% Gains Ahead For The Holdings of IWC
April 24, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
March 24, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
Tags
SLS
ADXN
GSK
From
Benzinga
Analysts Expect 50% Upside For IWV
March 23, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company
March 20, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
Tags
Covid/19
Trading Ideas
NTUS
From
Benzinga
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
March 19, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
XCUR
Top Stories
SRDX
From
Benzinga
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
March 17, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
Tags
Guidance
PCRX
News
From
Benzinga
Stocks That Hit 52-Week Lows On Monday
March 16, 2020
On Monday, 2568 stocks hit new 52-week lows. Areas of Significance: Amazon.com(NASDAQ: AMZN)is the largest company ...
Tags
MBCN
SCS
Forest Products
From
Benzinga
OptiNose, Inc. (OPTN) Q4 2019 Earnings Call Transcript
March 05, 2020
OPTN earnings call for the period ending December 31, 2019.
Tags
Market News
OPTN
From
Motley Fool
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
March 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
OPTN
CODX
CUE
From
Benzinga
Optinose Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Operational Highlights
March 05, 2020
From
GlobeNewswire News Releases
The Week Ahead In Biotech: COVID-19 Stocks In The Spotlight, Earnings Taper Off
February 29, 2020
Biotech stocks came under significant weakness along with the broader market in the week ended Feb. 28. Despite fears the COVID-19 ...
Tags
URGN
IPOs
FGEN
From
Benzinga
Optinose to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 5, 2020
February 27, 2020
Conference Call and Webcast Scheduled for Thursday, March 5 at 7:30 a.m. Eastern Time
From
GlobeNewswire News Releases
Currax Pharmaceuticals Delivers Strong Operational and Financial Performance Eight Months into Operations
February 27, 2020
- Exceeded 2019 growth expectations, generating over $70M of revenue in eight months and substantial cash flow, enabling 30% debt reduction
From
PR Newswire
Investors Snatch OPTN 32.3% Cheaper Than Its Secondary Stock Offering
February 24, 2020
Looking back to 95 days ago, OptiNose Inc (OPTN) priced a 5,500,000 share secondary stock offering at $9.75 per share. Buyers in that offering made a considerable investment into the company, expecting...
Tags
Stocks
From
Market News Video
Optinose Appoints Victor Clavelli as Chief Commercial Officer
February 19, 2020
From
GlobeNewswire News Releases
OptiNose is Now Oversold (OPTN)
February 07, 2020
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Tags
Stocks
From
Market News Video
Sum Up The Parts: BIB Could Be Worth $73
January 21, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Land This Bargain Even Cheaper Than Director Scodari Did
January 03, 2020
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 6, OptiNose Inc's Director, Joseph C..
Tags
Stocks
From
Market News Video
60 Biggest Movers From Friday
December 23, 2019
Gainers LAIX Inc. (NYSE: LAIX) shares jumped 85.5% to close at $7.68 on Friday. Marinus Pharmaceuticals Inc (NASDAQ: MRNS) ...
Tags
SHLO
KRTX
TXG
From
Benzinga
Benzinga's Top Upgrades, Downgrades For December 18, 2019
December 18, 2019
Upgrades JP Morgan upgraded the stock for Alexandria Real Estate Equities Inc (NYSE: ARE) from Neutral to Overweight. For the ...
Tags
FBIO
COLD
ALLO
From
Benzinga
IBB's Holdings Imply 18% Gain Potential
December 18, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Optinose Announces Peer-Reviewed Publication of the Fourth Major XHANCE Registration Trial
December 17, 2019
From
GlobeNewswire News Releases
Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 26, 2019
From
GlobeNewswire News Releases
66 Biggest Movers From Yesterday
November 22, 2019
Gainers Stage Stores, Inc. (NYSE: SSI) shares surged 52% to close at $3.39 on Thursday after the company reported Q3 ...
Tags
TLRY
APHA
IPAR
From
Benzinga
Here’s Why Shares of Optinose Crashed Today
November 21, 2019
A secondary offering resets the valuation of the ear, nose, and throat specialist.
Tags
Market News
OPTN
From
Motley Fool
45 Stocks Moving In Thursday's Mid-Day Session
November 21, 2019
Gainers Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) shares climbed 59.7% to $3.8650 after the thinly-traded, nano-cap biotech ...
Tags
LAIX
JG
Trading Ideas
From
Benzinga
Optinose Announces Pricing of Public Offering of Common Stock
November 21, 2019
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.